Effects of intravenous administration of FR122047 (a selective cyclooxygenase 1 inhibitor) and FR188582 (a selective cyclooxygenase 2 inhibitor) on prostaglandin-E2-induced aqueous flare elevation in pigmented rabbits

Ophthalmic Research

Volumn 36, Issue 6, 2004, Pages 321-326

  Abe, Tomohiro ^a   Hayasaka, Yoriko ^a   Zhang, Xue Yun ^a   Hayasaka, Seiji ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Aqueous flare; Cyclooxygenase 1; Cyclooxygenase 2; Prostaglandin E2; Rabbit eyes

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE SODIUM PHOSPHATE; DICLOFENAC; FR 122047; FR 188582; GLASS; MESSENGER RNA; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CILIARY BODY; CONTROLLED STUDY; CORNEA; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; IRIS; LASER FLARE CELL METER; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AQUEOUS HUMOR; BLOOD-AQUEOUS BARRIER; CILIARY BODY; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAVENOUS; IRIS; ISOENZYMES; MALE; PIPERAZINES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RABBITS; RNA, MESSENGER; THIAZOLES; UVEITIS, ANTERIOR;

EID: 11244289336     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081634     Document Type: Article

References (22)

1. 2 on rabbit eyes. Nippon Ganka Gakkai Zasshi 1994;98:927-934.
2. 2 to the cornea in pigmented rabbits. Ophthalmic Res 1996;28:147-152.
3. 2-induced aqueous flare elevation in pigmented rabbits. Arch Ophthalmol 2002;120:950-953.
4. 2-induced aqueous flare elevation in pigmented rabbits. Ophthalmic Res 2003;35:341-344.
5. Morita I: Distinct function of COX-1 and COX-2. Prostaglandins Lipid Mediat 2002;68-69:165-175.
6. Loftin CD, Tiano HF, Langenbach R: Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. Prostaglandins Lipid Mediat 2002;68-69:177-185.
7. Parente L, Perretti M: Advances in the pathophysiology of constitutive and inducible cyclooxygenases: Two enzymes in the spotlight. Biochem Pharmacol 2003;65:153-159.
8. To K, Abelson MB, Neufeld A: Nonsteroidal anti-inflammatory drugs; in Albert DM, Jacobiec FA (eds): Principles and Practice of Ophthalmology. Philadelphia, Saunders Co, 1994, pp 1022-1027.
9. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97-120.
10. Ochi T, Motoyama Y, Goto T: The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmacol 2000;391:49-54.
11. Ochi T, Goto T: Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. Br J Pharmacol 2002;135:782-788.
12. Ochi T, Sugiyama AY, Ohkubo Y, Sakane K, Tanaka H: The anti-inflammatory effect of FR188582, a highly selective inhibitor of cyclooxygenase-2, with an ulcerogenic sparing effect in rats. Jpn J Pharmacol 2001;85:175-182.
13. Sawa M, Tsurimaki Y, Tsuru T, Shimizu H: New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol 1988;32:132-142.
14. Damm J, Rau T, Maihofner C, Pahl A, Brune K: Constitutive expression and localization of COX-1 and COX-2 in rabbit iris and ciliary body. Exp Eye Res 2001;72:611-621.
15. Maihofner C, Schlotzer-Schrehardt U, Gubring H, Zeilhofer HU, Nauman GOH, Pahl A, Mardin C, Tamm E, Brune K: Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes. Invest Ophthalmol Vis Sci 2001;42:2616-2624.
16. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA: Selective inhibition of cyclooxygenase-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-2679.
17. 2. J Biol Chem 1997;272:25693-25699.
18. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, Herschman HR: In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol Exp Ther 1994;270:1340-1344.
19. Ristimaki A, Narko K, Hla T: Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation. Biochem J 1996;318:325-331.
20. Migita K, Tanaka H, Okamoto K, Yoshikawa N, Ichinose Y, Urayama S, Yamasaki S, Ida H, Kawabe Y, Kawakami A, Eguchi K: FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts. Lab Invest 2000;80:135-141.
21. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M, Jakobsson PJ, Crofford LJ: Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 2001;167:469-474.
22. Goppelt-Struebe M: Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochem Pharmacol 1997;53:1389-1395.